Merdan FAYDA - Overview

Work Experience and Education

Istinye University Medical Faculty, Professor Doctor (2017 – Continued)
Istine University Medical Faculty Associate Professor Doctor (2016 – 2017)
Liv Hospital Radiation Medicine Center, Tbilisi, Georgia, Radiation Oncology Consulting Docor (2016 – Continued)
Liv Hospital, Radiation Oncology (2015 – Continued)
Istanbul University Oncology Institution, Associate Professor (2012 – 2015)
Stereotactic Radiotherapy, Thoracic Oncology, University of North Carolina, NC, USA (2010 – 2011)
Kocaeli University Radiation Oncology Department, Associate Professor Assistant (2006 – 2009)
GATA Radiation Oncology Department, Specialist Doctor, Reserve Officer (2004 – 2005)
Istanbul University, Medical Faculty, Dr.R.A. (1999 – 2004)
Istanbul University, Medical Faculty, Under-Graduate (1993 – 1999)


Istinye University Medical Faculty
Liv Hospital Ulus
Istanbul University Oncology Institution
University of North Carolina, NC, USA
Kocaeli University Medical Faculty
Istanbul University, Medical Faculty

Interests Area 

Three Dimensional Brachytherapy
Four Dimensional (4D) Radiotherapy
Stereotactic RT & IMRT
Breast Cancer, Gynecological Cancers
Head – Neck Cancers
Urological Tumors, Gastrointestinal Cancers
Lung Cancer
Central Nervous System Tumors & Metastases
Skin Cancers
Soft Tissue Tumors

 Researches and Publications


Tambaş M, Fayda M. Central Nervous System Cancer in Elderly. Saka B, editor. Geriatric Oncology. Ankara: Turkey Clinic; 2018. p. 28-35
Fayda M, Isin M, Tambas M, Guveli M, Meral R, Altun M, Sahin D, Ozkan G, Sanli Y, Isin H, Ozgur E, Gezer U. Do Circulating Long Non-Coding RNAs (lncRNAs) (LincRNA-p21, GAS 5, HOTAIR) Predict the Treatment Response in Patients with Head and Neck Cancer Treated with Chemoradiotherapy? Tumor Biology, 2015, 19 October, DOI: 10.1007/s13277-015-4189-1.
Onder S, Fayda M, Karanlık H, Bayram A, Şen F, Cabioglu N, Tuzlalı S, İlhan R, Yavuz E. Loss of ARID1A expression is associated with poor prognosis in invasive micropapillary carcinomas of the breast: A clinicopathologic and immunohistochemical study with long-term survival analysis. Breast J. 2017 May 23. doi: 10.1111/tbj.12823. [E-pub ahead of print]
Fayda M, Gezer U. GAS5 oligonucleotides as therapeutic agents in breast cancer. Trans Cancer Res 2016. doi: 10.21037/tcr.2016.08.4
Fayda M, Tambaş, M, Karanlık H. Is sentinel lymph node biopsy enough for auxiliary macrometastasis? Turkish Journal of Surgery, 2015, Vol.31(4), pp.253-255.


49 Publications

Association Memberships

TROD (Turkish Radiation Oncology Association)
ASCO (American Soicety of Clinical Oncology)
ASTRO (American Society for Radiation Oncology)
ESTRO (European Society for Radiation Oncology)
Neuro-Oncology Association

What our patients say about the doctor

No Comment

Add Review